Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Lund

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
Open Heart|September 5, 2025
Prevalence and importance of coronary microvascular dysfunction in patients with heart failure and reduced or mildly reduced ejection fractionCharlotte Nordberg Backelin, Sara Svedlund, Entela Bollano, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 UpdateAxel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
Pflugers Archiv : European Journal of Physiology|October 9, 2024
ACE2 and TMPRSS2 in human kidney tissue and urine extracellular vesicles with age, sex, and COVID-19Marie Lykke Bach, Sara Laftih, Jesper K Andresen, et al.
BJU International|August 5, 2016
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional studyTommy K Nielsen, Brunolf W Lagerveld, Francis Keeley, et al.
Scientific Reports|September 1, 2023
CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effectsPratibha Dhumale, Jakob Vennike Nielsen, Anne Cathrine Schmidt Hansen, et al.
European Urology|May 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines PanelUmberto Capitanio, Patricia Zondervan, Riccardo Campi, et al.
European Journal of Heart Failure|April 8, 2017
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term RegistryOvidiu Chioncel, Mitja Lainscak, Petar M Seferovic, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Journal of Heart Failure|June 26, 2022
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?Magdy Abdelhamid, Giuseppe Rosano, Marco Metra, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
Open Heart|September 5, 2025
Prevalence and importance of coronary microvascular dysfunction in patients with heart failure and reduced or mildly reduced ejection fractionCharlotte Nordberg Backelin, Sara Svedlund, Entela Bollano, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 UpdateAxel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
Pflugers Archiv : European Journal of Physiology|October 9, 2024
ACE2 and TMPRSS2 in human kidney tissue and urine extracellular vesicles with age, sex, and COVID-19Marie Lykke Bach, Sara Laftih, Jesper K Andresen, et al.
BJU International|August 5, 2016
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional studyTommy K Nielsen, Brunolf W Lagerveld, Francis Keeley, et al.
Scientific Reports|September 1, 2023
CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effectsPratibha Dhumale, Jakob Vennike Nielsen, Anne Cathrine Schmidt Hansen, et al.
European Urology|May 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines PanelUmberto Capitanio, Patricia Zondervan, Riccardo Campi, et al.
European Journal of Heart Failure|April 8, 2017
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term RegistryOvidiu Chioncel, Mitja Lainscak, Petar M Seferovic, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Journal of Heart Failure|June 26, 2022
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?Magdy Abdelhamid, Giuseppe Rosano, Marco Metra, et al.
Pageof 22